ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Nov. 9-21. Deal Watc
ScripBEIJING - After a 10-month investigation, China’s Ministry of Public Security (MPS) has formally charged that GlaxoSmithKline PLC ex-China head Mark Reilly and two Chinese executives offered bribe
ScripGlaxoSmithKline PLC ’s new drug approvals in core areas demonstrate the big pharma is delivering on its R&D promises and establishing near-term sales, CEO Andrew Witty said during the company’s third
ScripBEIJING – China’s vaccine segment took off in 2007 when the government doubled its national vaccination program coverage to 14 vaccines, and the segment has maintained 15% annual growth. The expansion